Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank86
3Y CAGR+97.2%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+97.2%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
7.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $21.97M | -17.0% |
| 2024 | $26.47M | +325.2% |
| 2023 | $6.22M | +117.4% |
| 2022 | $2.86M | +290.1% |
| 2021 | $734000.00 | +192.9% |
| 2020 | $-790000.00 | +23.5% |
| 2019 | $-1.03M | -6356.3% |
| 2018 | $-16000.00 | +100.0% |
| 2017 | $-126.00M | +80.6% |
| 2016 | $-649.00M | - |